The practical administration of palivizumab in the general pediatric setting to prevent RSV infection

被引：0

作者：

Frogel, M ^{[1
]}

Nerwen, C ^{[1
]}

Bogaró, B ^{[1
]}

机构：

[1] Long Isl Jewish Med Ctr, Schneider Childrens Hosp, Div Gen Pediat, New Hyde Park, NY 11042 USA

来源：

PEDIATRIC RESEARCH | 2000年 / 47卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

1117

引用

页码：190A / 190A

页数：1

共 50 条

[1] Palivizumab (Synagis) for prevention of RSV infection
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1999, 41 (1043): : 3 - 4
[2] A Systematic Review of Compliance with Palivizumab Administration for RSV Immunoprophylaxis
Frogel, Michael P.
Stewart, Dan L.
Hoopes, Michael
Fernandes, Ancilla W.
Mahadevia, Parthiv J.
JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (01): : 46 - 58
[3] An outpatient program for administration of palivizumab prophylaxis for respiratory syncitial virus (RSV) in a subacute pediatric hospital
Gonzalez, F
Ballard, D
Hirsch, D
PEDIATRIC RESEARCH, 2002, 51 (04) : 218A - 218A
[4] Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection
Robinson, RF
Nahata, MC
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (03) : 259 - 264
[5] Apnea with RSV infection in three infants receiving palivizumab
Del Vecchio, Michael Thomas
PEDIATRICS INTERNATIONAL, 2013, 55 (06) : E159 - E161
[6] Immunoprophylaxis of RSV infection: Advancing from RSV-IGIV to palivizumab and motavizumab
Wu, H.
Pfarr, D. S.
Losonsky, G. A.
Kiener, P. A.
HUMAN ANTIBODY THERAPEUTICS FOR VIRAL DISEASE, 2008, 317 : 103 - 123
[7] Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab
Canfield, SD
Simoes, EAF
PEDIATRIC ANNALS, 1999, 28 (08): : 507 - +
[8] Passive immunisation of preterm infants with palivizumab against RSV infection
Harkensee, C
Brodlie, M
Embleton, ND
Mckean, M
JOURNAL OF INFECTION, 2006, 52 (01) : 2 - 8
[9] AAP Issues Updated Guidance on Palivizumab Prophylaxis for RSV Infection
Lambert, Mara
AMERICAN FAMILY PHYSICIAN, 2014, 90 (12) : 867 - 868
[10] Palivizumab: Preferred agent for prevention of RSV infection in high risk infants
不详
Drugs & Therapy Perspectives, 2000, 16 (2) : 1 - 5

← 1 2 3 4 5 →